Contineum Therapeutics, Inc. (CTNM) KPIs and segments

CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30

$9.86+0.08 (+0.82%)

Close on Nov 13, 2026Market cap $370.94MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Contineum Therapeutics's business

Coming soon

This tab will track the numbers specific to Contineum Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?